Evidence map›Paper›PMID 33310753›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2021

Mutant Huntingtin Is Cleared from the Brain via Active Mechanisms in Huntington Disease.

Nicholas S Caron, Raul Banos, Christopher Yanick, Amirah E Aly, Lauren M Byrne, Ethan D Smith, Yuanyun Xie, Stephen E P Smith, Nalini Potluri, Hailey Findlay Black and 9 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 65 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. The glymphatic system in Huntington's disease.Journal of Huntington's disease · 2025
    Review
  8. Diffusion along Perivascular Spaces as a Marker for Glymphatic System Impairment in Huntington's Disease.Movement disorders : official journal of the Movement Disorder Society · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 8 institutions in 4 countries.

Nicholas S CaronCentre for Molecular Medicine and Therapeutics, British Columbia Children's Hospital Research Institute, Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia V5Z 4H4, Canada.
Raul BanosBurnett School of Biomedical Sciences, University of Central Florida, Orlando, Florida 32828.
Christopher YanickBurnett School of Biomedical Sciences, University of Central Florida, Orlando, Florida 32828.
Amirah E AlyCentre for Molecular Medicine and Therapeutics, British Columbia Children's Hospital Research Institute, Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia V5Z 4H4, Canada.
Lauren M ByrneUCL Huntington's Disease Centre, UCL Queen Square Institute of Neurology, University College London, London, WC1N 3BG, United Kingdom.
Ethan D SmithBurnett School of Biomedical Sciences, University of Central Florida, Orlando, Florida 32828.
Yuanyun XieBurnett School of Biomedical Sciences, University of Central Florida, Orlando, Florida 32828.
Stephen E P SmithSeattle Children's Research Institute, Center for Integrative Brain Research, Seattle, Washington 98101.
Nalini PotluriBurnett School of Biomedical Sciences, University of Central Florida, Orlando, Florida 32828.
Hailey Findlay BlackCentre for Molecular Medicine and Therapeutics, British Columbia Children's Hospital Research Institute, Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia V5Z 4H4, Canada.
Lorenzo CasalCentre for Molecular Medicine and Therapeutics, Vancouver, British Columbia V5Z 4H4, Canada.
Seunghyun KoCentre for Molecular Medicine and Therapeutics, Vancouver, British Columbia V5Z 4H4, Canada.
Daphne CheungCentre for Molecular Medicine and Therapeutics, Vancouver, British Columbia V5Z 4H4, Canada.
Hyeongju KimDepartment of Biological Sciences, KAIST, Daejeon, Korea, 34141.
Ihn Sik SeongDepartment of Neurology, Massachusetts General Hospital, Boston, Massachusetts 02114.
Edward J WildUCL Huntington's Disease Centre, UCL Queen Square Institute of Neurology, University College London, London, WC1N 3BG, United Kingdom.
Ji-Joon SongDepartment of Biological Sciences, KAIST, Daejeon, Korea, 34141.
Michael R HaydenCentre for Molecular Medicine and Therapeutics, British Columbia Children's Hospital Research Institute, Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia V5Z 4H4, Canada amber.southwell@ucf.edu mrh@cmmt.ubc.ca.
Amber L SouthwellBurnett School of Biomedical Sciences, University of Central Florida, Orlando, Florida 32828 amber.southwell@ucf.edu mrh@cmmt.ubc.ca.
University of Central Florida · USPacific Centre for Reproductive Medicine · CABC Children's Hospital · CAKorea Advanced Institute of Science and Technology · KRUniversity of British Columbia · CAMassachusetts General Hospital · USNational Hospital for Neurology and Neurosurgery · GBUniversity College London · GB

Funding

Delineating factors that modulate huntingtin secretion and its role in Huntington disease pathogenesisR01NS116099 · NINDS · UNIVERSITY OF CENTRAL FLORIDA · PI SOUTHWELL, AMBER L · 2020 to 2024
$2.1M
CIHR FDN-154278Medical Research Council MR/M008592/1NINDS NIH HHS R01 NS116099
6 · The paper itself

Abstract

Huntington disease (HD) is a neurodegenerative disease caused by a CAG trinucleotide repeat expansion in the huntingtin (

Indexed as

Brain ChemistryAnimalsAstrocytesBiomarkersFemaleGlymphatic SystemHumansHuntingtin ProteinHuntington DiseaseMaleMiceMice, TransgenicMutationNeuronsTrinucleotide Repeat ExpansionBiomarkersHTT protein, humanHuntingtin Proteinbiomarkercerebrospinal fluidglymphatic systemHuntington diseaseneurodegenerationprotein secretion

Identifiers

PMID33310753
PMCPMC7842749
OpenAlexW3110716355

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.